Yeboah Joseph, Sane David C, Crouse John R, Herrington David M, Bowden Donald W
Department of Internal Medicine/Cardiology, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA.
Dis Markers. 2007;23(3):173-8. doi: 10.1155/2007/962892.
We tested associations of the growth factors VEGF, FGF-2, HGF and PDGF-BB with coronary artery calcium scores and cardiovascular events (CVD) in type 2 diabetes mellitus (T2DM).
A cross-sectional study selected 40 frequency matched (by age, gender and race) subjects with T2DM from the first (0-111) and the third (> 1400) coronary artery calcium (CAC) score tertiles in the Diabetes Heart Study (DHS), in which 36 were with and 41 were without history of CVD events. Plasma levels of VEGF, FGF-2, HGF and PDGF-BB were measured in all subjects.
None of the growth factors was significantly different between the first and third CAC score tertiles. Mean plasma FGF-2 and PDGF-BB levels were significantly higher in the group without prior CVD events compared with the group with prior CVD events [mean(95%CI): 219.20 (194.42-247.15) vs. 152.93 (135.64-172.43) pg/ml, p=0.03] and [mean(95%CI): 106.70 (89.12-127.74) vs. 61.56 (50.91-74.44) pg/ml, p=0.03], respectively. Subgroup analysis in the first CAC tertile showed a significantly higher PDGF-BB levels in those without compared with those with CVD events [mean (95%CI): 208.36 (190.57-228.15) vs. 102.93 (80.64-125.21) pg/ml, p=0.004].
Plasma growth factor levels were not significantly different between the extremes of CAC scores in T2DM. However, low plasma levels of PDGF-BB and FGF-2 are associated with prior cardiovascular events in T2DM. Studies are needed to confirm our results and also to establish temporality of this association.
我们检测了生长因子血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(FGF-2)、肝细胞生长因子(HGF)和血小板衍生生长因子BB(PDGF-BB)与2型糖尿病(T2DM)患者冠状动脉钙化积分及心血管事件(CVD)之间的关联。
一项横断面研究从糖尿病心脏研究(DHS)中冠状动脉钙化(CAC)积分处于第一(0 - 111)和第三(> 1400)三分位数的患者中,按年龄、性别和种族频率匹配选取了40例T2DM患者,其中36例有CVD事件病史,41例无CVD事件病史。检测了所有受试者血浆中VEGF、FGF-2、HGF和PDGF-BB的水平。
在CAC积分的第一和第三三分位数之间,这些生长因子均无显著差异。与有CVD事件病史的组相比,无CVD事件病史组的血浆FGF-2和PDGF-BB平均水平显著更高[均值(95%可信区间):219.20(194.42 - 247.15)pg/ml对152.93(135.64 - 172.43)pg/ml,p = 0.03]以及[均值(95%可信区间):106.70(89.12 - 127.74)pg/ml对61.56(50.91 - 74.44)pg/ml,p = 0.03]。在CAC积分第一三分位数的亚组分析显示,无CVD事件的患者PDGF-BB水平显著高于有CVD事件的患者[均值(95%可信区间):208.36(190.57 - 228.15)pg/ml对102.93(80.64 - 125.21)pg/ml,p = 0.004]。
T2DM患者中,CAC积分极端值之间的血浆生长因子水平无显著差异。然而,低血浆水平的PDGF-BB和FGF-2与T2DM患者既往心血管事件相关。需要开展研究以证实我们的结果,并确定这种关联的时间顺序。